Helminth-derived immunomodulatory molecules

Advances in Experimental Medicine and Biology

Volumn 666, Issue , 2009, Pages 95-107

  Adisakwattana, Poom ^b   Saunders, Sean P ^b   Nel, Hendrik J ^b   Fallon, Padraic G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE BINDING PROTEIN; CYSTATIN; CYTOKINE; ES 62; GAMMA INTERFERON; GLYCAN DERIVATIVE; GLYCOLIPID; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOMODULATING AGENT; LACTO N FUCOPENTAOSE III; LYSOPHOSPHATIDYLSERINE; MACROPHAGE MIGRATION INHIBITION FACTOR; ONCHOCYSTATIN; PHOSPHORYLCHOLINE; THIOREDOXIN PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

ALLERGIC DISEASE; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; ASCARIS; ASTHMA; AUTOIMMUNITY; CELIAC DISEASE; CELL PROTECTION; CHEMOTAXIS; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HELMINTH; HELMINTHIASIS; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MULTIPLE SCLEROSIS; NECATOR AMERICANUS; NONHUMAN; ONCHOCERCA VOLVULUS; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SPECIES DIFFERENTIATION; TH2 CELL; TRICHURIS SUIS; ANIMAL; PHYSIOLOGY; REVIEW;

VERMES;

ANIMALS; HELMINTHS; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES;

EID: 75649115748     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1601-3_8     Document Type: Article

References (85)

1. Fallon PG, Mangan NE. Suppression of TH2-type allergic reactions by helminth infection. Nat Rev Immunol 2007; 7:220-230.
2. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy,parasites and the hygiene hypothesis. Science 2002; 296:490-494.
3. Maizels RM, YazdanbakhshM. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3:733-744. (Pubitemid 41070814)
4. Harnett W. Goodridge HS, Hamett MM. Subversion of immune cell signal transduction pathways by the secreted filarial nematode product, ES-62. Parasitology 2005: 130(Suppl):S63-68. (Pubitemid 41626592)
5. Fallon PG, Alcami A. Pathogen-derived immunomodulatory molecules: furure immunotherapeutics? Trends Immunol 2006; 27:470-476. (Pubitemid 44354309)
6. Dunne DW; Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005; 5:420-426. (Pubitemid 40685991)
7. van den Biggelaar AHJ, van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-l0. The Lancet 2000; 356:1723-1727.
8. Araujo MI, Lopes AA, Medeiros M et al. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000; 123:145-148.
9. Flohr C, Tuyen LN, Lewis S et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional studyJ Allergy Clin Immunol 2006: 118:1305-1311. (Pubitemid 44883190)
10. Jorge Correale ME Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology 2007; 61:97-108.
11. Jorge Correale MFGR. Helminth infections associated with multiple sclerosisinduce regulatory B-cells. Annals of Neurology 2008; 64:187-199.
12. Resende Co T, Hcs Toossi Z et al. Intestinal helminth eo-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 2007; 147:45-52. (Pubitemid 44915554)
13. Summers RW; Elliott DE, Urban JF et al. Trichuris suis therapy in Crohn's disease. Gut 2005; 54:87-90. (Pubitemid 40007223)
14. Summers RW;Elliotr DE, Urban JJF et al. Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 2005; 128:825-832. (Pubitemid 40523535)
15. Croese J, O'Neil J, Masson J et al.A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006; 55:136-137. (Pubitemid 41820655)
16. Falcone FH, DI Pritchard. Parasite role reversal: worms on trial. Trends Parasitol2005; 21:157-160. (Pubitemid 40381251)
17. Leonardi-Bee J, Pritchard D. Britton J. The parasites in asthma collaboration. Asthma and current intestinal parasite infection: systematic review and rneta-analysis. Am J Respir Crit Care Med 2006; 174:514-523. (Pubitemid 44330543)
18. Smith P, Mangan NE, Walsh CM et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 2007; 178:4557-4566. (Pubitemid 46492408)
19. Hunter MM. Wang A. McKay DM. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 2007; 132:1320-1330. (Pubitemid 46627574)
20. Mangan NE. van Rooijen N. McKenzie AN et al. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immuno12006; 176:138-147. (Pubitemid 43023257)
21. Kradin RL, Badizadegan K, Auluck P et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med 2006; 130:718-720. (Pubitemid 43736877)
22. Summers RW. Elliott DE. Qadir K et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenrerol 2003; 98:2034-2041. (Pubitemid 37185802)
23. Mortimer K, Brown A. Feary J et al. Dose-ranging study for trials of therapeutic infection with Necator Americanus in humans. Am J Trop Med Hyg 2006;75:914-920. (Pubitemid 351627540)
24. Doetze A. Satoguina J, Burchard G et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Trl-type cytokines IL-I0 and transforming growth factor-S but not by a Th l to Th2 shilft Int Immunol 2000; 12:623-630. (Pubitemid 30248895)
25. Schnoeller C. Rausch S. Pillai S et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-l O-producing macrophages. J Immunol 2008; 180:4265-4272.
26. McInnes IB. Leung BP, Harnecc M et al. A Novel therapeutic approach targeting areicular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003; 171:2127-2133. (Pubitemid 36966497)
27. Melendez AJ, Harnecc MM. Pushparaj PN et al. Inhibition of Fcskl-mediaced mast cell responses by ES-62, a product of parasitic filarial nematodes. Nar Med 2007; 13:1375-1381. (Pubitemid 350073593)
28. Okano M, Satoskar AR. Nishizaki K et al. Lacro-Nfucopenraose III Found on Schitosorna mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol 2001; 167:442-450. (Pubitemid 32567810)
29. Thomas PG. Career MR. Da'dara AA et al. A Helminth glycan induces APC maturation via alternative NF-KB activation independent of IKBa degradation. J Immunol2005; 175:2082-2090. (Pubitemid 41113813)
30. van der Kleij D, Latz E. Brouwers JFHM et al. A Novel Host-Parasite Lipid Cross-talk. SchistosomaJ lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Bioi Chem 2002; 277:48122-48129. (Pubitemid 35470760)
31. Jenkins SJ. Hewitson JP, Jenkins GR. Modulation of the host's immune response by schistosome larvae. Parasite Immunol 2005; 27:385-393. (Pubitemid 41413486)
32. Smith P. Fallon RE. Mangan NE et al. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 2005; 202:1319-1325. (Pubitemid 41668734)
33. Donnelly S, O'Neill SM. Sekiya M. Thioredoxin peroxidase secreted by Fasciola heparica induces the alternative activation of macrophages. Infect Immun 2005; 73: 166-173. (Pubitemid 40041106)
34. Donnelly S, Stack CM. O'Neill SM et al. Helminth 2-Cys peroxiredoxin drives 1h2 responses through a mechanism involving alcernacively activated macrophages. FASEB J 2008; 22:4022-4032.
35. Grencis RK. Entwistle GM. Production of an interferon-gamma homologue by an intestinal nematode: functionally significant or interesting artefact? Parasitology 1997; 115(Suppl):SlOl-106.
36. Gnanasekar M. Velusamy R, He Y-X. Cloning and characterization of a high mobility group box 1 (HMGBl) homologue protein from Schistosoma mansoni. Mol Biochem Parasitol 2006; 145:137-146. (Pubitemid 43083356)
37. Zang X. Taylor P, Wang JM et al. Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity and crystal structure. J Biol Chem 2002; 277:44261-44267. (Pubitemid 36157859)
38. Gnanasekar M, K Ramaswamy. Translationally controlled tumor protein of Brugia malayi functions as an antioxidant protein. Parasitol Res 2007; 101:1533-1540. (Pubitemid 47524835)
39. Gomez-Escobar N, Lewis E. Maizels RM. A Novel member of the transforming growth factor-β (TGF-β) superfamily from the filarial nematodes Brugia malayi and B. pahangi. Exp Parasitol 1998; 88:200-209. (Pubitemid 28375787)
40. Hamett W; IB McInnes, MM Harnecc. ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potential. Immunol Lett 2004; 94:27-33. (Pubitemid 38953708)
41. Houston KM. Wilson EH. Eyres L et al. Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-l0-dependent mechanism. Infect Immun 2000; 68:5466-5468.
42. Goodridge HS. McGuiness S. Houston KM et al. Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells. Parasite Immunol 2007; 29:127-137. (Pubitemid 46239262)
43. Goodridge HS, Marshal! FA, Else KJ et al. Immunomodulation via novel use of TLR4 by the filarial nematode Phosphorylcholine-Containing secreted product, ES-62.J Immuno12005; 174:284-293. (Pubitemid 40007415)
44. Mountford AP, Trottein F.Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 2004; 20:221-226. (Pubitemid 38510318)
45. Ramaswamy K, He YX, SalafskyB. ICAM-l and iNOS expression increased in the skin ofmice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni. Exp Parasitol 1997; 86: 118-132. (Pubitemid 27293627)
46. Trottein F, Descamps L, Nutten S et al. Schistosoma mansoni activates host microvascular endothelial cells to acquire an anti-inflammatory phenotype. Infect Immun 1999; 67:3403-3409. (Pubitemid 29291509)
47. Valle C, Fesrucci A, Calogero A et al. Stage-specific expression of a Schistosoma mansoni polypeptide similar to the vertebrate regulatory protein Srathmin.J Biol Chem 1999; 274:33869-33874. (Pubitemid 129511713)
48. Rao KV, He YX, Ramaswamy K. Suppression of cutaneous inflammation by intradermal gene delivery. Gene Ther 2002; 9:38-45. (Pubitemid 34145166)
49. Holmfeldt P, Brännströrn K, Sellin ME et al.The Schistosoma mansoni protein SmI6/SmSLP/SmSPO-l is a membrane-binding protein that lacks the proposed microtubule-regulatory activity. Mol Biochem Parasitol 2007; 156:225-234. (Pubitemid 47600375)
50. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003; 3:36-50. (Pubitemid 37328698)
51. Schramm G, Falcone FH, Gronow A et al. Molecular Characterization of an Interleukin-4-inducing factor from Schistosoma mansoni eggs.J Biol Chem 2003; 278:18384-18392. (Pubitemid 36799460)
52. Kim K, Kim IH, Lee KY et al. The isolation and purification of a specific "protector" protein which inhibits enzyme inactivation by a thioIlFe(III)/02 mixed-function oxidation system.J Biol Chem 1988; 263:4704-4711.
53. Chandrashekar R, Curtis KC, Lu W et al. Molecular cloning of an enzymatically active thioredoxin peroxidase from Onchocerca volvulus. Mol Biochem Parasitol 1998; 93:309-312. (Pubitemid 28277067)
54. Kwatia MA, Botkin DJ, Williams DL. Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase. J Parasitol 2000; 86:908-915.
55. Margutti P, Ortona E, Delunardo F et al. Thioredoxin peroxidase from Echinococcus granulosus: a candidate to extend the antigenic panel for the immunodiagnosis of human cystic echinococcosis. Diagn Microbiol Infect Dis 2008; 60:279-285. (Pubitemid 351253606)
56. Dzik JM. Molecules released by helminth parasites involved in host colonization. Acta Biochim Pol 2006; 53:33-64.
57. Henkle-Diihrsen K, Karnpkotter A. Antioxidant enzyme families in parasitic nematodes. Mol Biochem Parasitol 2001; 114:129-142. (Pubitemid 32510750)
58. Hartmann S, Lucius R. Modulation of host immune responses by nematode cysratins. Int J Parasitol 2003; 33:1291-1302. (Pubitemid 37101475)
59. Lustigman S, Brotman B, Huima T et al. Molecular cloning and characterization of onchocystarin, a cysteine proteinase inhibitor of Onchocerca volvulus.J Biol Chem 1992;267:17339-17346.
60. Schonemeyer A, Lucius R, Sonnenburg B et al. Modulation of human T'-cell responses and macrophage functions by Onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus.J Immunol 2001; 167:3207-3215. (Pubitemid 32852560)
61. MurrayJ, Manoury B, Balic A et al. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP. Mol Biochem Parasitol 2005; 139:197-203. (Pubitemid 40128215)
62. Morales FC, Furtado DR, Rumjanek FD. The N-terminus moiety of the cysratin SmCys from Schistosoma mansoni regulates its inhibitory activity in vitro and in vivo. Mol Biochem Parasitol 2004; 134:65-73. (Pubitemid 38121519)
63. van der Kleij D, Yazdanbakhsh M. Control of inflammatory diseases by pathogens: lipids and the immune system. EurJ Immunol 2003; 33:2953-2963. (Pubitemid 37428327)
64. Thomas PG, Ham DA. Immune biasing by helminth glycans. Cellular Microbiology 2004; 6:13-22. (Pubitemid 38111585)
65. Capron A, Riveau G, Capron M. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005; 21:143-149. (Pubitemid 40269779)
66. Velupillai P, Ham DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ celis from schistosome-infected mice: a mechanism for regulation of CD4+ Tvcell subsets. Proc Natl Acad Sci USA 1994; 91:18-22.
67. Velupillai P, Secor WE, Horauf Ham AM. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158:338-344. (Pubitemid 127483874)
68. Terrazas LI, Walsh KL, Piskorska D et al. The schistosome oligosaccharide lacto-N-neotetraose expands Grl+ cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4+ cells: A potential mechanism for immune polarization in helminth infections. J Immunol 2001; 167:5294-5303. (Pubitemid 33009768)
69. Atochina0, Daly-Engd T, Piskorska 0 et al. A Schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Grl + macrophages that suppress naive CD4+ T cell proliferation via an IFN-y and nitric oxide-dependent mechanism. J Immunol 2001; 167:4293-4302. (Pubitemid 32954304)
70. ArochinaO Da'dara AA, Walker M. The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology 2008; 125:111-121.
71. Thomas PG, Carter MR, Atochina O. et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-Like Recepcor 4-dependent mechanism. J Immunol 2003: 171:5837-5841. (Pubitemid 37467200)
72. van der Kleij D, van Rernoortere A. Schuitemaker JHN et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GaINAcβI-4 (Fucαl -2Fucαl -3)GlcNAc. J Infect Dis 2002; 185:531-539. (Pubitemid 34142816)
73. VermeireJJ. Cho Y. Lolis E et al. Orrhologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol 2008; 24:355-363.
74. Senter PD, Al-Abed Y, Metz CN et al. Inhibition of macrophage migration inhibitory factor (MIF) taurornerase and biological activities by acetaminophen rnetabolires. Proc Natl Acad Sci USA 2002; 99:144-149. (Pubitemid 34060331)
75. Rodriguez-Sosa M, Rosas LE, David JR et al. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 2003; 71:1247-1254. (Pubitemid 36254308)
76. Cho Y, Jones BF, VerrneireJJ et al. Structural and functional characterization of a secreted hookworm macrophage migration inhibitory factor (MIF) that interacts with the human MIF rcceptor CD74. J Biol Chem 2007; 282:23447-23456. (Pubitemid 47311922)
77. Beall MJ, McGonigle S, Pearce EJ. Functional conservation of Schistosoma mansoni Smads in TGF-β signaling. Mol Biochem Parasitol 2000; 111:131-142.
78. Beall MJ, Pearce EJ. Human transforming growth factor-beta activates a receptor serine/threonine kinase ftom the intravascular parasite Schistosoma mansoni. J Biol Chem 2001; 276:31613-31619 .
79. Osman A, Nib EG, LoVerde PT. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a tran sform ing growth factor-beta signal tran sducer. J Biol Chem 2001; 276:10072-10082.
80. Osman A, Nib EG, LoVerde PT. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation. J Biol Chem 2004; 279:6474-6486. (Pubitemid 38248781)
81. Osrnan A, Niles EG, Verjovski-Almeida S et al. Schistosoma mansoni TGF-beta rccepror Il : role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog 2006; 2:e54.
82. Zavala-Gongora R, Kroner A. Wittek B et al. Identification and characterisation of two distinct Smad proteins from the fox-tapeworm Echinococcus multilocularis, Int J Parasitol 2003; 33:1665-1677. (Pubitemid 37433999)
83. Bornmcr UA, Thiek BJ. The translationally controlled tumour prote in (TCTP). Inr J Biochem Cell Biol 2004; 36:379-385.
84. Gnanasekar M. Rao KVN, Chen L. et al. Molecular characterization of a calcium binding translationally controlled tumor protein homologue from the filarial parasites Brugia malayi and Wuchereria bancrohi , Mol Biochem Parasitol 2002; 121:107-118. (Pubitemid 34457838)
85. Bianchi ME. Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220:35-46. (Pubitemid 350045574)